Asia Pacific
By Chris Wallbridge Few places exemplify a fast pace of change quite like Shanghai. Things continue to change at a lightning speed, with new technology and use-cases over a matter of months disrupting and re-inventing business...
Discoveries: ESOMAR APAC 2017 , Shanghai
By Lifeng Liu Welcome to China, my homeland. I appreciate this opportunity to introduce you to China. On one hand, China is a leading emerging country within the new world economy, and on the other hand...
Looking Beyond – Data, Data Everywhere
A report from the MRSI’s 26th Annual Conference By Umesh Kumar I recently had the pleasure to attend the Market Research Society of India’s 26th annual conference, whose theme was “Looking Beyond”. Today, in an...
なごう!– Tsunagou! It’s Japanese for “Let’s Get Connected!”
An overview of what to look forward too at ESOMAR's forthcoming APAC Conference....
How do Clinicians in the JAPAC Region View Biosimilars?
By Ross McKinnon and Talia S. Foster, M.S. Biosimilars may offer lower-cost versions of existing biologic therapies – but a survey of Japan/Asia/Pacific (JAPAC) clinicians finds some confusion regarding differences between original biologics and biosimilars that may...
ESOMAR Asia Pacific 2012 – Day 1
Comprehensive highlights from RWC's reporter on the ground at ESOMAR's Asia Pacific 2011 conference in Shanghai....